The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
On May 6, Anavex Life Sciences' Board of Directors appointed Terrie Kellmeyer, PhD, as Interim Chief Executive Officer. This appointment follows the resignation of former CEO Christopher Missling on April 30, 2026, after a request for his resignation from the Board.